However, lack of comprehensive genetic testing is the limitation of this study, as up to 2.6% of patients with prolactinoma without related MEN1 symptoms may experience mutations in the MEN1 gene (66). This evidence concerns the gene MEN1 and prolactin-producing pituitary gland adenoma.